VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹33 Cr | ₹32 Cr | ₹52 Cr | ₹59 Cr | ₹40 Cr |
What is the latest Total Current Liabilities ratio of VAISHALI PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹33 Cr |
Mar2023 | ₹32 Cr |
Mar2022 | ₹52 Cr |
Mar2021 | ₹59 Cr |
Mar2020 | ₹40 Cr |
How is Total Current Liabilities of VAISHALI PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹33 Cr | 3.16 | |
Mar2023 | ₹32 Cr | -38.26 | |
Mar2022 | ₹52 Cr | -12.36 | |
Mar2021 | ₹59 Cr | 46.63 | |
Mar2020 | ₹40 Cr | - |
Compare Total Current Liabilities of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹205.9 Cr | -5.2% | 10.4% | -3.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,044.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,537.0 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
CIPLA | ₹118,889.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,075.0 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,832.5 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | -5.2% |
10.4% |
-3.4% |
SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses